Venmax Drugs and Pharmaceuticals informs about disclosure

05 May 2025 Evaluate
Pursuant to SEBI Circular dated August 10, 2021, with regard to fund raising by issuance of debt securities by large entities, Venmax Drugs and Pharmaceuticals has informed that the Company does not fulfil the criteria specified in the above-mentioned SEBI Circular and hence as on 31st March 2025 the company does not fall in the category of ‘Large Corporate’.

The above information is a part of company’s filings submitted to BSE.

Venmax Drugs&Pharma Share Price

24.85 -1.14 (-4.39%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×